Literature DB >> 29705933

Mesenchymal Stem Cells Form 3D Clusters Following Intraventricular Transplantation.

Nicole Jungwirth1,2, Laura Salinas Tejedor2,3, Wen Jin1,2, Viktoria Gudi2,3, Thomas Skripuletz3, Veronika Maria Stein4, Andrea Tipold2,4, Andrea Hoffmann5, Martin Stangel2,3, Wolfgang Baumgärtner6,7, Florian Hansmann1,2.   

Abstract

Mesenchymal stem cells (MSCs) are regarded as an immune privileged cell type with numerous regeneration-promoting effects. The in vivo behavior of MSC and underlying mechanisms leading to their regenerative effects are largely unknown. The aims of this study were to comparatively investigate the in vivo behavior of canine (cMSC), human (hMSC), and murine MSC (mMSC) following intra-cerebroventricular transplantation. At 7 days post transplantation (dpt), clusters of cMSC, hMSC, and mMSC were detected within the ventricular system. At 49 dpt, cMSC-transplanted mice showed clusters mostly consisting of extracellular matrix lacking transplanted MSC. Similarly, hMSC-transplanted mice lacked MSC clusters at 49 dpt. Xenogeneic MSC transplantation was associated with a local T lymphocyte-dominated immune reaction at both time points. Interestingly, no associated inflammation was observed following syngeneic mMSC transplantation. In conclusion, transplanted MSC formed intraventricular cell clusters and exhibited a short life span in vivo. Xenogeneically in contrast to syngeneically transplanted MSC triggered a T cell-mediated graft rejection indicating that MSCs are not as immune privileged as previously assumed. However, MSC may mediate their effects by a "hit and run" mechanism and future studies will show whether syngeneically or xenogeneically transplanted MSCs exert better therapeutic effects in animals with CNS disease.

Entities:  

Keywords:  CD44; Canine mesenchymal stem cells; Cell clusters; Host versus graft reaction; Human mesenchymal stem cells; Mesenchymal stem cells

Mesh:

Year:  2018        PMID: 29705933     DOI: 10.1007/s12031-018-1070-x

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  48 in total

Review 1.  Mesenchymal stem cells: clinical applications and biological characterization.

Authors:  Frank P Barry; J Mary Murphy
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

2.  Immunophenotype and gene expression profile of mesenchymal stem cells derived from canine adipose tissue and bone marrow.

Authors:  Rudell Screven; Elizabeth Kenyon; Michael J Myers; Haile F Yancy; Mark Skasko; Lynne Boxer; Elmer C Bigley; Dori L Borjesson; Min Zhu
Journal:  Vet Immunol Immunopathol       Date:  2014-07-01       Impact factor: 2.046

3.  Isolation, characterization, and differentiation potential of canine adipose-derived stem cells.

Authors:  N M Vieira; V Brandalise; E Zucconi; M Secco; B E Strauss; M Zatz
Journal:  Cell Transplant       Date:  2009-12-08       Impact factor: 4.064

4.  Isolation, culture and chondrogenic differentiation of canine adipose tissue- and bone marrow-derived mesenchymal stem cells--a comparative study.

Authors:  Christine M Reich; Oksana Raabe; Sabine Wenisch; Philip S Bridger; Martin Kramer; Stefan Arnhold
Journal:  Vet Res Commun       Date:  2012-03-04       Impact factor: 2.459

5.  HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.

Authors:  Katarina Le Blanc; Charlotte Tammik; Kerstin Rosendahl; Eva Zetterberg; Olle Ringdén
Journal:  Exp Hematol       Date:  2003-10       Impact factor: 3.084

6.  Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6.

Authors:  Ryang Hwa Lee; Andrey A Pulin; Min Jeong Seo; Daniel J Kota; Joni Ylostalo; Benjamin L Larson; Laura Semprun-Prieto; Patrice Delafontaine; Darwin J Prockop
Journal:  Cell Stem Cell       Date:  2009-07-02       Impact factor: 24.633

7.  Canine mesenchymal stem cells (MSCs): characterization in relation to donor age and adipose tissue-harvesting site.

Authors:  Annalisa Guercio; Santina Di Bella; Stefania Casella; Patrizia Di Marco; Carmelo Russo; Giuseppe Piccione
Journal:  Cell Biol Int       Date:  2013-04-11       Impact factor: 3.612

8.  Limited remyelination in Theiler's murine encephalomyelitis due to insufficient oligodendroglial differentiation of nerve/glial antigen 2 (NG2)-positive putative oligodendroglial progenitor cells.

Authors:  R Ulrich; F Seeliger; M Kreutzer; P-G Germann; W Baumgärtner
Journal:  Neuropathol Appl Neurobiol       Date:  2008-05-05       Impact factor: 8.090

9.  Immunophenotyping of immune cell populations in the raccoon (Procyon lotor).

Authors:  Franziska Heinrich; Nicole Jungwirth; Regina Carlson; Andrea Tipold; Michael Böer; Thomas Scheibe; Viktor Molnár; Katja von Dörnberg; Ingo Spitzbarth; Christina Puff; Peter Wohlsein; Wolfgang Baumgärtner
Journal:  Vet Immunol Immunopathol       Date:  2015-11-03       Impact factor: 2.046

10.  Fate of transplanted bone marrow derived mesenchymal stem cells following spinal cord injury in rats by transplantation routes.

Authors:  Eun-Sun Kang; Kee-Yong Ha; Young-Hoon Kim
Journal:  J Korean Med Sci       Date:  2012-05-26       Impact factor: 2.153

View more
  9 in total

1.  Chemotherapy-Free Targeted Anti-BCR-ABL+ Acute Lymphoblastic Leukemia Therapy May Benefit the Heart.

Authors:  Hanna Kirchhoff; Melanie Ricke-Hoch; Katharina Wohlan; Stefan Pietzsch; Ümran Karsli; Sergej Erschow; Robert Zweigerdt; Arnold Ganser; Matthias Eder; Michaela Scherr; Denise Hilfiker-Kleiner
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

2.  Meta-Analysis of Percutaneous Endomyocardial Cell Therapy in Patients with Ischemic Heart Failure by Combination of Individual Patient Data (IPD) of ACCRUE and Publication-Based Aggregate Data.

Authors:  Mariann Gyöngyösi; Evgeny Pokushalov; Aleksander Romanov; Emerson Perin; Joshua M Hare; Jens Kastrup; Francisco Fernández-Avilés; Ricardo Sanz-Ruiz; Anthony Mathur; Wojcieh Wojakowski; Enca Martin-Rendon; Noemi Pavo; Imre J Pavo; Rayyan Hemetsberger; Denise Traxler; Andreas Spannbauer; Paul M Haller
Journal:  J Clin Med       Date:  2022-06-04       Impact factor: 4.964

3.  Cell-Based HIF1α Gene Therapy Reduces Myocardial Scar and Enhances Angiopoietic Proteome, Transcriptomic and miRNA Expression in Experimental Chronic Left Ventricular Dysfunction.

Authors:  Edit Gara; Sang-Ging Ong; Johannes Winkler; Katrin Zlabinger; Dominika Lukovic; Bela Merkely; Maximilian Y Emmert; Petra Wolint; Simon P Hoerstrup; Mariann Gyöngyösi; Joseph C Wu; Noemi Pavo
Journal:  Front Bioeng Biotechnol       Date:  2022-05-12

4.  A Comparison of Immune Responses Exerted Following Syngeneic, Allogeneic, and Xenogeneic Transplantation of Mesenchymal Stem Cells into the Mouse Brain.

Authors:  Jung Won Hwang; Na Kyung Lee; Je Hoon Yang; Hyo Jin Son; Sa Ik Bang; Jong Wook Chang; Duk L Na
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

5.  BDNF-overexpressing human mesenchymal stem cells mediate increased neuronal protection in vitro.

Authors:  Verena Scheper; Jana Schwieger; Anika Hamm; Thomas Lenarz; Andrea Hoffmann
Journal:  J Neurosci Res       Date:  2019-06-30       Impact factor: 4.164

6.  Aggregation of Human Mesenchymal Stromal Cells Eliminates Their Ability to Suppress Human T Cells.

Authors:  Anthony J Burand; Lin Di; Lauren K Boland; Devlin T Boyt; Michael V Schrodt; Donna A Santillan; James A Ankrum
Journal:  Front Immunol       Date:  2020-02-25       Impact factor: 7.561

7.  Neocortical tissue recovery in severe congenital obstructive hydrocephalus after intraventricular administration of bone marrow-derived mesenchymal stem cells.

Authors:  María García-Bonilla; Betsaida Ojeda-Pérez; María L García-Martín; M Carmen Muñoz-Hernández; Javier Vitorica; Sebastián Jiménez; Manuel Cifuentes; Leonor Santos-Ruíz; Kirill Shumilov; Silvia Claros; Antonia Gutiérrez; Patricia Páez-González; Antonio J Jiménez
Journal:  Stem Cell Res Ther       Date:  2020-03-17       Impact factor: 6.832

8.  Highly Proliferative Immortalized Human Dental Pulp Cells Retain the Odontogenic Phenotype when Combined with a Beta-Tricalcium Phosphate Scaffold and BMP2.

Authors:  Xiangfen Li; Liu Wang; Qin Su; Ling Ye; Xuedong Zhou; Dongzhe Song; Dingming Huang
Journal:  Stem Cells Int       Date:  2020-02-15       Impact factor: 5.443

Review 9.  Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities.

Authors:  Xueying Zhang; Qi Xie; Ziyu Ye; Yanyun Li; Zhengping Che; Mingyuan Huang; Jincheng Zeng
Journal:  Front Immunol       Date:  2021-07-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.